2 ND WIPO INTER-REGIONAL MEETING ON SOUTH-SOUTH COOPERATION ON PATENTS, TRADEMARKS, GEOGRAPHICAL INDICATIONS, INDUSTRIAL DESIGNS AND ENFORCEMENT CAIRO.

Slides:



Advertisements
Similar presentations
Caribbean Central American Action (CCAA) Strengthening in the Third Border (CBI) CCA 27 th Annual Miami Conference on the Caribbean Basin Dr Rosanna Cooper,
Advertisements

4 th Global Congress Combating Counterfeiting & Piracy Dubai, February 3-8, 2008 Challenge 7 : Strengthening Cooperation and Collaboration at the Global.
Impact of JUSFTA on affordability and availability of medicines from perspective of local generic manufacturers Towards equitable and affordable medicine.
Intellectual property rights and procurement = international developments & national experiences = Bi-regional Workshop on procurement and supply management.
WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies (19-23 September 2005) TRADE, TRIPS AND ACCESS TO MEDICINES Cecilia Oh Department.
Durban, South Africa January 29 to 31, 2013 Topic 8: Compulsory Licenses Regional Seminar for Certain African Countries on the Implementation and Use of.
WIPO-Ministry of Foreign Affairs-ASRT
Dubai Conference May 2004 Molengraaff Institute Center for Intellectual Property Law (CIER) 2 OVERVIEW Domain Concepts Methodologies Problematic Issues.
Dissemination and Use of Copyrighted Works for Education and Research Mohammed El Said (UCLAN) Arab-African Seminar on Exceptions and Limitations Cairo.
WIPO NATIONAL SEMINAR ON OMANI TRADITIONAL VALUES IN A GLOBALIZED WORLD Muscat, February 13 and 14, 2005 International Legal Framework for the Protection.
What is TRIPS ? TRIPS is The Agreement on Trade-Related Aspects of Intellectual Property Rights, Including Trade in Counterfeit Goods. TRIPS is one of.
The TRIPS Agreement and Public Health
WIPO NATIONAL SEMINAR ON INDUSTRIAL PROPERTY AND ON THE IMPLEMENTATION OF TRIPS OBLIGATIONS IN THE PURSUANCE OF NATIONAL PUBLIC POLICIES AND GOALS Damascus,
Working world wide against HIV for the health and human rights of men who have sex with men Working world wide against HIV for the health and human rights.
1 WTO and medicines: from Doha to Cancún Germán Velásquez Essential Drugs and Medicines Policy World Health Organization Geneva, October 2003.
2 nd WIPO Inter-Regional Meeting on South- South Cooperation on Patents, Trademarks, Geographical Indications, Industrial Designs and Enforcement Cairo.
Actions Developing in Countries Accessing the WTO System Vung Tau, February 2006 “US – Brazil Compulsory licensing.
WTO Dispute DS362 China vs. United States
XIX International AIDS Conference July 2012 Washington DC, USA The Brazilian experience: the campaign for access to lopinavir/ritonavir and efavirenz compulsory.
Challenges and Opportunities to Utilize TRIPS Flexibilities in Current Ukrainian Legislation: Potential Impact of IP Provisions in the Proposed EU FTA.
Intellectual Property, Free Trade Agreements and sustainable Development Hanan Sboul Secretary General/ The Jordanian Association of Pharmaceutical Manufacturers.
Exception to rules on free trade Need to strike a balance between free trade and other values. Member can justify measures incompatible with WTO Agreements.
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
1 Intellectual Property Rights in Medicines Procurement Patrick Osewe Senior HIV/AIDS Specialist World Bank.
A very short introduction to patents & access to medicines.
TRIPS flexibilities and examples which resulted in reduced medicine prices: Model legislation and compulsory licensing in Brazil Juliana V. Borges Vallini.
Patent Related Flexibilities in the Pharmaceutical Field
Public health, innovation and intellectual property 1 |1 | Dr Germán Velásquez Director WHO Secretariat Public Health, Innovation and Intellectual Property.
Importance of Intellectual Property Central issue in multilateral trade relations –Need for organization to see that there are intellectual property procedures.
IPR enforcement in the EU Evidence of impact of on the access to generics Johanna von Braun University of Cape Town, South Africa Kiev, 21/22 nd June 2010.
Why is protecting pharmaceutical patents a controversial issue in DCs? Poor DCs can neither produce nor afford to buy patented drugs. They need generic.
The emergence of an Enforcement Agenda Intellectual Property Rights and Access to Essential Medicines: Challenges and Opportunities in Free Trade Agreement.
PATENTS AND HEALTH. A CASE STUDY OF THE UGANDAN CONTEXT. (PHA3 JULY 7 TH 2012 –CAPE TOWN, SOUTH AFRICA) MS. MARIAM AKIROR LLB (HONS) / DIP. SW / CPC. PROG.
TRIPS Flexibilities P. Roffe ICTSD Bellagio, October 2007.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
CAPACITY BUILDING TRAINING PROGRAMME ON INTELLECTUAL PROPERTY RIGHTS AND RELATED WTO ISSUES April 28-May 2, 2008 Session 3 Enforcement under the TRIPS.
Impacts of TRIPS on access to care The post-2005 issues Benjamin CORIAT University Paris 13 and ANRS ANRS – MoH Brazil Satellite Meeting Mexico, August.
What are the TRIPS flexibilities? How will their incorporation in patent legislation promote access to essential medicines? IP and Access to Medicines:
Ten Years of the Doha Declaration: The State of Implementation Geneva 14 November
Session 6 : An Introduction to the TRIPS Agreement UPOV, 1978 and 1991 and WIPO- Administered Treaties.
Chinese Foreign Trade Law Jiaxiang Hu Professor of Law, School of Law, SJTU.
The Doha Declaration and the Protocol amending the TRIPS Agreement Islamabad, 28 November 2007 Octavio Espinosa WIPO.
UNCTAD/CD-TFT 1 Exclusive Rights and Public Access – Flexibilities in International Agreements and Development Objectives The Public Health Example 21.
O VERVIEW OF P UBLIC H EALTH -R ELATED TRIPS F LEXIBILITIES Sisule F. Musungu, IQsensato (
© 2008 International Intellectual Property June 24, 2009 Class 8 Patents: Multilateral Agreements (WTO TRIPS); Global Problem of Patent Protection for.
UNCTAD/CD-TFT 1 IP Provisions in Bilateral & Regional Trade Agreements and Public Health ICTSD/QUNO Dinner Discussion on IPRs in Bilateral & Regional Trade.
UNCTAD/CD-TFT 1 Basic Features of the Multilateral Systems of Patents and Regulatory Test Data Development Dimensions of Intellectual Property Rights Hanoi.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
A: Copy –Rights – Artistic, Literary work, Computer software Etc. B: Related Rights – Performers, Phonogram Producers, Broadcasters etc. C: Industrial.
Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies By Yvonne Nkrumah Legal Counsel, Ghana Food and Drugs Board.
SM © 2012 Patterson Thuente Christensen Pedersen, P.A., some rights reserved - DISCLAIMER: This presentation and any information.
No Incentive To Innovator Prior To 1st January 2005 Prior to 1st January 2005, the Indian Patent Act (1970) allowed only for process patents in all areas.
WTO and the TRIPS Agreement Wolf R. MEIER-EWERT WTO Secretariat A Business-oriented overview of Intellectual Property for Law Students WIPO, Geneva 20.
A presentation by Moses Nkomo Intellectual Property Attorney and Consultant National Workshop on TRIPS and access to medicines in Zimbabwe Holiday Inn,
Implementation of TRIPS Flexibilities In National IP Legislation For Strengthening Access To Medicines In Swaziland Workshop with MOH and stakeholders,
Victor H. Bouganim WCL, American University
Intellectual Property and Public Policy: Application of Flexibilities in the International IP and Trade system --Limitation and Exceptions for Education.
Copyright Protection in Indonesia: General Information on the Implementation of Copyright Law in Indonesia; policies and planning Seoul, November 2007.
Overview: The South African IP Policy Review 13 September 2012 MacDonald Netshitenzhe: Chief Director- Policy and Legislation.
NAFTA, CAFTA and Access to Medicines and Food Security in Latin America International Aids Conference Session “Globalization and FTAs: their impact, access.
Overview of presentation
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
Designing a Dynamic IP System in the Republic of Belarus
Exception to rules on free trade
Intellectual Property Protection and Access to Medicines
Access to Treatment: People Before Trade
PATENTS, TRIPS, FLEXIBILITIES & ACCESS TO MEDICINES
IP Protection under the WTO
Department Of Commerce
IP Provisions in Bilateral & Regional Trade Agreements and Public Health ICTSD/QUNO Dinner Discussion on IPRs in Bilateral & Regional Trade Agreements.
Presentation transcript:

2 ND WIPO INTER-REGIONAL MEETING ON SOUTH-SOUTH COOPERATION ON PATENTS, TRADEMARKS, GEOGRAPHICAL INDICATIONS, INDUSTRIAL DESIGNS AND ENFORCEMENT CAIRO 6-8 MAY 2013 DR. MOHAMMED EL SAID (UCLAN, UK) Patent-Related Flexibilities in Multilateral Treaties and their Importance for Developing Countries and LDCs

Summary Meaning of flexibilities Development of flexibilities Categories of flexibilities Impact Recommendations and final thoughts

Meaning of flexibilities? policy space which includes a range of rights, safeguards and options that countries can exploit in their implementation of IP obligations

Flexibilities: Purpose: striking the balance TRIPS Non uniform in nature: depending on each country Non automatic applicability: such options, must be incorporated under national law

Historical development of flexibilities Emerging trend: reduction in policy space Total freedom Paris and Berne Conventions 1883 and 1889 National treatment MFN TRIPS Agreement and the notion of Minimum standards TRIPS-Plus and the reduction of policy space

General categories of Flexibilities under TRIPS First: Implementation flexibilities Second: Substantive standards flexibilities Third: Enforcement related flexibilities

First: Implementation flexibilities Art 1.1 of TRIPS stipulates that: Members shall be free to determine the appropriate method of implementing the provisions of this Agreement within their own legal system and practice. Example, Transition periods. LDCs under 2013 and 2016 respectively

Second: Substantive standards flexibilities Defining subject matter of protection Patents: patentability criteria Exceptions, example of patents: Compulsory licensing and government use Education, experimental and personal use Parallel importation Regulatory review (Bolar exception) Utility models Procedural flexibilities: pre and post-grant oppositions

Third: Enforcement related flexibilities TRIPS first ever to deal with enforcement measures. General guidelines Enforcement procedures to effective action against IP infringement IP Enforcement Procedures shall be fair and equitable Parties to a proceeding shall have an opportunity for review by a judicial authority of final administrative decisions No obligation to put in place a IP distinct judicial system Border measures: Art 51 applies to two types of IP infringements: Counterfeited trademarks Pirated copyrighted goods NO OBLIGATION ON PATENTS No requirement to adopt provisional measures ex officio or specialized courts.

Importance and Impact Parallel importation reduced the price of first-line anti-retroviral medicines to one-third of the price of the patented version in Kenya. Oxfam (2006) Malaysia became the first country in Asia to issue a government use licence for the importation of generic ARVs in This reducing the average cost of the Malaysians MoH treatment per patient per month from US $315 to US $58, an 81% reduction. Khor (2007) Ecuador latest country to issue one for ARVS in The License immediately reduced cost of drug by 27%

Importance and Impact Indias use of transition period Indias use of patentability criteria (sec 3.d) In march 2013, supreme court rejected Novartis application for Gleevec as it did not consider it new invention. Gleevec, for example, can cost as much as $70,000 a year, while Indian generic versions cost about $2,500 a year.

Importance and impact Following the declaration of government use for the ARV treatment lopinavir/ritonavir in 2008, the number of patients in Thailand using lopinavir/ritonavir has reportedly increased from 39 to 6,246. In February 2007, the patent holder announced a global price reduction on efavirenz, benefiting HIV/AIDS patients around the world. WHO/WTO/WIPO 2013

Developing and LDCs challenges WIPO Study Patent Flexibilities 2010 With regard to regulatory review (Bolar) exception, of the 95 countries with available information, only 56% had integrated it into their patent legislation. The percentage of countries integrating this flexibility varied from 0% (0/20) for least developed countries to 93% (25/27) for high-income countries. With regard to parallel imports, an analysis of the legislation of 112 countries showed that 29 (26%) have an international exhaustion regime, 36 (32%) have a regional exhaustion regime, thus allowing for parallel imports, and 42 (37.5%) have a national exhaustion regime.

Regional perspective incorporation vrs application Arab countries incorporation (largely) Arab countries application (v poor utilization)

Threats and Challenges Incorporation of flexibilities Easy, user friendly Awareness about their use Checks and balances Collaborative effort nationally Regional cooperation International agenda Rejection of TRIPS-Plus conditions (FTAs)

Thank you